Abstract
A novel computational approach was examined tor predicting epitopes from primary structures of the seven immunologically distinct botulinum neurotoxins (BoNT/A-G) and tetanus toxin (TeTX). An artificial neural network [Rost and Sander (1994), Proteins 20, 216] was used to estimate residue solvent accessibilities in multiple aligned sequences. A similar network trained to predict secondary structures was also used to examine this protein family, whose tertiary fold is presently unknown. The algorithm was validated by showing that it was 80% accurate in determining the secondary structure of avian egg-white lysozyme and that it correctly identified highly solvent-exposed residues that correspond to the major contact regions of lysozyme–antibody cocrystals. When sequences of the heavy (H) chains of TeTX and BoNT/A–G were analyzed, this algorithm predicted that the most highly exposed regions were clustered at the sequentially nonconserved N- and C-termini [Lebeda and Olson (1994), Proteins 20, 293]. The secondary structures and the remaining highly solvent-accessible regions were, in contrast, predicted to be conserved. In experiments reported by others, H-chain fragments that induced immunological protection against BoNT/A overlap with these predicted most highly exposed regions. It is also known that the C-terminal halves of the TeTX and BoNT/A H-chains interfere with holotoxin binding to ectoacceptors on nerve endings. Thus, the present results provide a theoretical framework for predicting the sites that could assist in the development of genetically engineered vaccines and that could interact with neurally located toxin ectoacceptors. Finally, because the most highly solvent-exposed regions were not well conserved, it is hypothesized that nonconserved, potential contact sites partially account for the existence of different dominant binding regions for type-specific neutralizing antibodies.
Article PDF
Similar content being viewed by others
REFERENCES
Atassi, M. Z. (1978). Precise determination of the entire antigenic structure of lysozyme, Immunochemistry 15, 909–936.
Atassi, M. Z., and Young, J. A. (1985). Discovery and implications of the immunogenicity of free small synthetic peptides, CRC Crit. Rev. Immunol. 5, 387–409.
Atassi, M. Z., Dolimbek, B. Z., Hayakari, M., Middlebrook, J. L., Whitney, B., and Ishima, M. (1996). Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855–1296 with antitoxin antibodies from three host species, J. Protein Chem. 15, 691–700.
Bizzini, B., Akert, K., Glicksman, M., and Grob, P. (1980). Preparation of conjugates using two tetanus toxin derived fragments: Their binding to gangliosides and isolated synaptic membranes and their immunological properties, Toxicon 18, 561–572.
Branden, B. C., Souchon, H., Eiselé, J.-L., Bentley, G. A., Bhat, T. N., Navaza, J., and Poljak, R. J. (1994). Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1, J. Mol. Biol. 243, 767–781.
Chitarra, V., Alzari, P. M., Bentley, G. A., Bhat, T. N., Eiselé, J.-L., Houdusse, A., Lescar, J., Souchon, H., and Poljak, R. J. (1993). Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex, Proc. Natl. Acad. Sci. USA 90, 7711–7715.
Clayton, M. A., Clayton, J. M., Brown, D. R., and Middlebrook, J. L. (1995). Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli, Infect. Immunol. 63, 2738–2742.
Dertzbaugh, M. T., and West, M. W. (1995). Identification of protective domains of botulinum neurotoxin serotype A, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 12.
Dertzbaugh, M. T., and West, M. W. (1996). Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum, Vaccine 14, 1538–1544.
Devereux, J., Haeberli, P., and Smithies, O. (1984). A comprehensive set of sequence analysis programs for the VAX, Nucleic Acids Res. 12, 387–395.
Dolly, J. O., Ashton, A. C., Evans, D. M., Richardson, P. J., Black, J. D., and Melling, J. (1987). Molecular action of botulinum neurotoxins: Role of acceptors in targetting to cholinergic nerves and in the inhibition of release of several transmitters, in Cellular and Molecular Basis of Cholinergic Function (Dowdall, M. J., ed.), Ellis Horwood, Chichester, England, pp. 517–533.
Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. (1984). Analysis of membrane and surface protein sequences with hydrophobic moment plot, J. Mol. Biol. 179, 125–142.
Fischmann, T. O., Bentley, G. A., Bhat, T. N., Boulot, G., Mariuzza, R. A., Phillip, S. E. V., Tello, D., and Poljak, R. J. (1991). Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-Å resolution, J. Biol. Chem. 266, 12915–12920.
Gallis, H. A. (1984). Streptococcus, in Zinsser Microbiology, 18th ed. (Joklik, W. K., Willett, H. P., and Amos, D. B., eds.), Appleton-Century-Crofts, Norwalk, Connecticut, pp. 463–476.
Getzoff, E. D., Geysen, H. M., Rodda, S. J., Alexander, H., Tainer, J. A., and Lerner, R. A. (1987). Mechanisms of antibody binding to a protein, Science 235, 1191–1196.
Geysen, H. M., Rodda, S. J., Mason, T. J., Tainer, J. A., Alexander, H., Getzoff, E., and Lerner, R. A. (1987a). Response to: Novotný et al., 1987, Science 238, 1584–1586.
Geysen, H. M., Tainer, J. A., Rodda, S. J., Masson, T. J., Alexander, H., Getzoff, E., and Lerner, R. A. (1987b). Chemistry of antibody binding to a protein, Science 235, 1184–1190.
Jameson, B. A., and Wolf, H. (1988). The antigenic index: A novel algorithm for predicting antigenic determinants, CABIOS 4, 181–186.
Kabsch, W., and Sander, C. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features, Biopolymers 22, 2577–2637.
Kanehisa, M. (1988). IDEAS-88, Integrated Database and Extended Analysis System for Nucleic Acids and Proteins, IDEAS User's Manual, Advanced Scientific Computing Laboratory, National Cancer Institute, Frederick Cancer Research Facility, Frederick, Maryland.
Lebeda, F. J., and Olson, M. A. (1994). Secondary structural predictions for the clostridial neurotoxins, Proteins: Struct. Funct. Gen. 20, 293–300.
Lebeda, F. J., and Olson, M. A. (1995). Structural predictions of the channel-forming region of botulinum neurototoxin heavy chain, Toxicon 33, 559–567.
Lebeda, F. J., Hack, D. C., and Gentry, M. K. (1994). Theoretical analyses of the functional regions of the heavy chain of botulinum neurotoxin, in Therapy with Botulinum Toxin (Jankovic, J., and Hallett, M., eds.), Marcel Dekker, New York, pp. 51–61.
Ledoux, D. N., Be, X.-H., and Singh, B. R. (1994). Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical crosslinking and native gel electrophoresis, Toxicon 32, 1095–1104.
Makoff, A. J., Ballantine, S. P., Smallwood, A. E., and Fairweather, N. F. (1989). Expression of tetanus toxin fragment C in E. coli: Its purification and potential use as a vaccine, Biotechnology 7, 1043–1046.
Middlebrook, J. L. (1994). Development of a molecularly engineered vaccine for botulinum toxin, Toxicon 32, 242.
Middlebrook, J. L. (1995). Development of a molecularly enginecred vaccine for botulinum toxin, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 16.
Montal, M. S., Blewitt, R., Tomich, J. M., and Montal, M. (1992). Identification of an ion channel-forming motif in the primary structure of tetanus and botulinum neurotoxins, FEBS Lett. 313, 12–18.
Novotný, J., and Auffray, C. (1984). A program for prediction of protein secondary structure from nucleic sequence data: Application to histocompatibility antigens, Nucleic Acids Res. 12, 243–255.
Novotný, J., Handschumacher, M., Haber, E., Bruccoleri, R. E., Carlson, W. B., Fanning, D. W., Smith, J. A., and Rose, G. D. (1986). Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains), Proc. Natl. Acad. Sci. USA 83, 226–230.
Novotný, J., Bruccoleri, R. E., Carlson, W. D., Handschumacher, M., and Haber, E. (1987). Antigenicity of myo-hemerythrin, Science 238:1584.
Padlan, E. A., Silverton, E. W., Sheriff, S., Cohen, G. H., Smith-Gill, S. J., and Davies, D. R. (1989). Structure of an antibody-antigen complex: Crystal structure of the HyHEL-10 Fab-lysozyme complex, Proc. Natl. Acad. Sci. USA 86, 5938–5942.
Rost, B., and Sander, C. (1993). Prediction of protein secondary structure at better than 70% accuracy, J. Mol. Biol. 232, 584–599.
Rost, B., and Sander, C. (1994a). Combining evolutionary information and neural networks to predict protein secondary structure, Proteins: Struct. Funct. Gen. 19, 55–72.
Rost, B., and Sander, C. (1994b). Conservation and prediction of solvent accessibility in protein families, Proteins: Struct. Funct. Gen. 20, 216–226.
Sander, C., and Schneider, R. (1991). Database of homology-derived structures and the structural meaning of sequence alignment, Proteins: Struct. Funct. Gen. 9, 56–68.
Schiavo, G., Rossetto, O., and Montecucco, C. (1994). Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release, Semin. Cell Biol. 5, 221–229.
Schuler, G. D., Altschul, S. F., and Lipman, D. J. (1991). A workbench for multiple alignment construction and analysis, Proteins: Struct. Funct. Gen. 9, 180–190.
Sheriff, T., Silverton, E. W., Padlan, E. A., Cohen, G. H., Smith-Gill, S. J., Finzel, B. C., and Davies, D. R. (1987). Three-dimensional structure of an antibody-antigen complex, Proc. Natl. Acad. Sci. USA 84, 8075–8079.
Simpson, L. L. (1984). The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin, J. Pharmacol. Exp. Ther. 229, 182–187.
Smith, L. A., Zuber, M., and Hoover, T. A. (1995). The protective efficacy of recombinant truncated He from Clostridium botulinum neurotoxin A, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 23.
Thornton, J. M., Edwards, M. S., Taylor, W. R., and Barlow, D. J. (1986). Location of ‘continuous’ antigenic determinants in the protruding regions of proteins, EMBO J. 5, 409–413.
VanCott, T. C., Bethke, F. R., Artenstein, A. W., McCutchan, F. E., McNeil, J. G., Mascola, J. R., Redfield, R. R., and Birx, D. L. (1994). Serotyping international HIV-1 isolates by V3 peptides and whole gp120 proteins using BIAcore, Methods: Companion Meth. Enzymol. 6, 188–198.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lebeda, F.J., Olson, M.A. Predicting Differential Antigen–Antibody Contact Regions Based on Solvent Accessibility. J Protein Chem 16, 607–618 (1997). https://doi.org/10.1023/A:1026370807586
Published:
Issue Date:
DOI: https://doi.org/10.1023/A:1026370807586